DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
批准号:
3180920
负责人:
SUSAN M ASTRIN
金额:
$22.76万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1989-04-04
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our long-range goal is to elucidate mechanisms of oncogene activation in
human tumors and to assess the possiblity that genetic lesions in
trans-acting regulators of oncogene expression play an important role in
this activation. Towards this goal, we have cloned the human c-myc gene to
generate probes to be used for quantitation of myc sequences in RNAs
prepared from a variety of human tumors. Using these probes, we have
observed elevated expression (greater than 10-fold above levels in normal
tissue) of the c-myc gene in tumor cells obtained from certain
leukemia/lymphoma and colon carcinoma patients. Studies with colon
carcinoma cell lines have shown that, in samples with elevated expression,
myc is deregulated; i.e., the normal cell cycle control is lost and the
gene is constitutively expressed. In addition, we have observed that, in
the vast majority of cases, elevated expression of the myc gene in the
tumor cells is not due to detectable rearrangements or amplification of the
myc locus itself. Further structural analysis of the myc locus in these
tumors will be performed using cloning and sequencing technology. Two
types of models for the activation, due to either cis-acting or
trans-acting elements, will be tested. In order to test for alterations at
the myc locus itself (cis-acting effects) which result in enhanced
expression, myc loci cloned from tumors will be tested for transcriptional
activity after transfection into recipient cells with low levels of
endogenous myc expression. To test for lesions at other loci which may
affect myc expression (trans-acting effects), cell fusions wil be performed
between tumor cells expressing myc at high levels and normal cells having
low levels of myc expression. Defective negative acting regulatory genes
in the tumor cells would be complemented in this assay by alleles in the
normal cells resulting in a low level of myc expression in the hybrid
cells. Experiments designed to test for positive acting regulatory
elements are also proposed. Ultimately, we would hope to clone and study
the products of any regulatory loci identified in this manner. (X)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ONCOGENIC POTENTIAL OF HIV
-
批准号:2114004
-
项目类别:
-
资助金额:$37.7万
-
财政年份:1995
-
负责人:SUSAN M ASTRIN
-
依托单位:
ONCOGENIC POTENTIAL OF HIV
-
批准号:2114003
-
项目类别:
-
资助金额:$35.2万
-
财政年份:1995
-
负责人:SUSAN M ASTRIN
-
依托单位:
ONCOGENIC POTENTIAL OF HIV
-
批准号:2748834
-
项目类别:
-
资助金额:$44.91万
-
财政年份:1995
-
负责人:SUSAN M ASTRIN
-
依托单位:
ONCOGENIC POTENTIAL OF HIV
-
批准号:2458237
-
项目类别:
-
资助金额:$43.93万
-
财政年份:1995
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180922
-
项目类别:
-
资助金额:$33.54万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:2090298
-
项目类别:
-
资助金额:$36.69万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180921
-
项目类别:
-
资助金额:$32.35万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180919
-
项目类别:
-
资助金额:$21.25万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180923
-
项目类别:
-
资助金额:$35.31万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180917
-
项目类别:
-
资助金额:$23.03万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180915
-
项目类别:
-
资助金额:$16.06万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
DEREGULATION OF ONCOGENE EXPRESSION IN HUMAN TUMORS
-
批准号:3180918
-
项目类别:
-
资助金额:$4.18万
-
财政年份:1985
-
负责人:SUSAN M ASTRIN
-
依托单位:
海外基金